The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency

Journal of Immunology

Volumn 170, Issue 2, 2003, Pages 805-815

  Hirst, Claire E ^a   Buzza, Marguerite S ^a   Bird, Catherina H ^a   Warren, Hilary S ^a   Cameron, Paul U ^a   Zhang, Manling ^a   Ashton Rickardt, Philip G ^a   Bird, Phillip I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GRANZYME B; PROTEINASE INHIBITOR; PROTEINASE INHIBITOR 9; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACCESSORY CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MATURATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; DENDRITIC CELL; EFFECTOR CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0037438474     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.2.805     Document Type: Article

References (95)

1. Berke, G. 1995. Unlocking the secrets of CTL and NK cells. Immunol. Today 16:343.
2. Motyka, B., G. Korbutt, M. J. Pinkoski, J. A. Heibein, A. Caputo. M. Hobman, M. Barry, L. Shostak, T. Sawchuk, C. F. Holmes, et al. 2000. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 103:491.
3. Alimonti, J. B., L. Shi, P. K. Baijal, and A. H. Greenberg. 2001. Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition. J. Biol. Chem. 276:6974.
4. Barry, M., J. A. Heibein, M. J. Pinkoski, S. F. Lee, R. W. Moyer, D. R. Green, and R. C. Bleackley. 2000. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol. Cell. Biol. 20:3781.
5. Heibein, J. A., I. S. Goping, M. Barry, M. J. Pinkoski, G. C. Shore, D. R. Green, and R. C. Bleackley. 2000. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J. Exp. Med. 192:1391.
6. Sutton, V. R., J. E. Davis, M. Cancilla, R. W. Johnstone, A. A. Ruefli, K. Sedelies, K. A. Browne, and J. A. Trapani. 2000. Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation. J. Exp. Med. 192:1403.
7. Andrade, F., S. Roy, D. Nicholson, N. Thomberry, A. Rosen, and L. Casciola-Rosen. 1998. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 8:451.
8. Yang, X., H. R. Stennicke. B. Wang, D. R. Green. R. U. Janicke, A. Srinivasan. P. Seth, G. S. Salvesen, and C. J. Froelich. 1998. Granzyme B mimics apical caspases: description of a unified pathway for trans-activation of executioner caspase-3 and -7. J. Biol. Chem. 273:34278.
9. Froelich, C. J., W. L. Hanna, G. G. Poirier, P. J. Duriez, D. D'Amours, G. S. Salvesen, E. S. Alnemri, W. C. Eamshaw, and G. M. Shah. 1996. Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment. Biochem. Biophys. Res. Commun. 227:658.
10. Thomas, D. A., C. Du, M. Xu, X. Wang, and T. J. Ley. 2000. DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity 12:621.
11. Sharif-Askari, E., A. Alam, E. Rheaume, P. J. Beresford, C. Scotto, K. Sharma, D. Lee, W. E. DeWolf, M. E. Nuttall, J. Lieberman, et al. 2001. Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J. 20:3101.
12. Stinchcombe, J. C., and G. M. Griffiths. 2001. Normal and abnormal secretion by haemopoietic cells. Immunology 103:10.
13. Spaeny-Dekking, E. H., W. L. Hanna, A. M. Wolbink, P. C. Wever, A. J. Kummer, A. J. Swaak, J. M. Middeldorp, H. G. Huisman. C. J. Froelich, and C. E. Hack. 1998. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 160:3610.
14. Lauw, F. N., A. J. Simpson, C. E. Hack, J. M. Prins, A. M. Wolbink, S. J. van Deventer. W. Chaowagul, N. J. White, and T. van Der Poll. 2000. Soluble granzymes are released during human endotoxemia and in patients with severe infection due to Gram-negative bacteria. J. Infect. Dis. 182:206.
15. + peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor, Blood 86:3500.
16. Froelich, C. J., X. Zhang, J. Turbov, D. Hudig, U. Winkler, and W. L. Hanna, 1993. Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. J. Immunol. 151:7161.
17. Ronday, H. K., W. H. van der Laan, P. P. Tak, J. A. de Roos, R. A. Bank, J. M. TeKoppele, C. J. Froelich, C. E. Hack, P. C. Hogendoom, F. C. Breedveld. et al. 2001. Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Rheumatology 40:55.
18. Gahring, L., N. G. Carlson, E. L. Meyer, and S. W. Rogers. 2001. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J. Immunol. 166:1433.
19. Sun, J., C. H. Bird, V. Sutton, L. McDonald, P. B. Coughlin, T. A. De Jong, J. A. Trapani, and P. I. Bird. 1996. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271:27802.
20. Bird, C. H., E. J. Blink, C. E. Hirst, M. S. Buzza. P. M. Steele, J. Sun, D. A. Jans, and P. I. Bird. 2001. Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crml. Mol. Cell. Biol. 21:5396.
21. Bird, C. H., V. R. Sutton, J. Sun, C. E. Hirst, A. Novak, S. Kumar. J. A. Trapani, and P. I. Bird. 1998. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol. 18:6387
22. Hirst, C. E., M. S. Buzza, V. R. Sutton, J. A. Trapani, K. L. Loveland, and P. I. Bird. 2001. Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction. Mol. Hum. Reprod. 7:1133.
23. Bladergroen, B. A., M. C. Strik, N. Bovenschen, O. van Berkum, G. L. Scheffer, C. J. Meijer, C. E. Hack, and J. A. Kummer. 2001. The granzyme B inhibitor protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J. Immunol. 166:3218.
24. Buzza, M. S., C. E. Hirst, C. H. Bird, P. Hosking, J. McKendrick, and P. I. Bird. 2001. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell. Immunol. 210:21.
25. Scott, F. L., J. E. Paddle-Ledinek, L. Cerruti, P. B. Coughlin, H. H. Salem, and P. I. Bird. 1998. Proteinase inhibitor 6 (PI-6) expression in human skin: induction of PI-6 and a PI-6/proteinase complex during keratinocyte differentiation. Exp. Cell. Res. 245:263.
26. Apostolidis, V. A., K. A. Browne, M. J. Smyth, and J. A. Trapani. 1995. The peptide loop consisting of amino acids 139-157 of human granzyme B (fragmentin 2) contains an immunodominant epitope recognized by the mouse. Mol. Immunol. 32:909.
27. Edwards, K. M., C. M. Kam. J. C. Powers, and J. A. Trapani. 1999. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes. J. Biol. Chem. 274:30468.
28. Zhang, X., and R. Ren. 1998. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 92:3829.
29. Bums, J. C., T. Friedmann, W. Driever. M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc. Natl. Acad. Sci. USA 90:8033.
30. Medhurst, A. D., D. C. Harrison, S. J. Read, C. A. Campbell, M. J. Robbins, and M. N. Pangalos. 2000. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods 98:9.
31. Leo, O. M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
32. Wano, Y., T, Uchiyama, K. Fukui, H. Uchino, and J. Yodoi. 1984. Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells. J.Immunol. 132:3005.
33. Liu, C. C., S. Rafii, A. Granelli-Piperno, J. A. Trapani, and J. D. Young. 1989. Perforin and serine esterase gene expression in stimulated human T cells: kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 170:2105.
34. Warren, H. S., and L. J. Skipsey. 1991. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcRγIII (CD16) molecule and NK cell differentiation. Immunology 72:150.
35. Warren, H. S., and B. F. Kinnear. 1999. Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation. J. Immunol. 162:735.
36. Sun, J., C. H. Bird, M. S. Buzza, K. E. McKee, J. C. Whisstock, and P. I. Bird. 1999. Expression and purification of recombinant human granzyme B from Pichia pastoris. Biochim. Biophys. Acta 261:251.
37. Zapata, J. M., R. Takahashi, G. S. Salvesen, and J. C. Reed. 1998. Granzyme release and caspase activation in activated human T-lymphocytes. J. Biol. Chem. 273:6916.
38. + subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 163:1409.
39. Olweus, J., A. BitMansour, R. Warnke, P. A. Thompson, J. Carballido, L. J. Picker, and F. Lund-Johansen. 1997. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc. Natl. Acad. Sci. USA 94:12551.
40. Romani, N., S. Gruner, D. Brang, E Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch. R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
41. Scott, F. L., C. E. Hirst, J. Sun, C. H. Bird, S. P. Bottomley. and P. I. Bird. 1999. The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin G. Blood 93:2089.
42. Stavridi, E. S., K. O'Malley, C. M. Lukacs, W. T. Moore, J. D. Lambris, D. W. Christianson, H. Rubin, and B. S. Cooperman. 1996. Structural change in α-chymotrypsin induced by complexation with α1-antichymotrypsin as seen by enhanced sensitivity to proteolysis. Biochemistry, 35:10608.
43. Huntington, J. A., R. J. Read, and R. W. Carrel. 2000. Structure of a serpinprotease complex shows inhibition by deformation. Nature 407:923.
44. Zang, X., and R. Ren. 1998. Bcr-Abl effeciently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimultating factor in mice: a novel model of chronic myelogenous leukemia. Blood 92:3829.
45. Isaaz, S., K. Baetz, K. Olsen, E. Podack, and G. M. Griffiths. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25:1071.
46. Vandenabeele, S., H. Hochrein, N. Mavaddat, K. Winkel, and K. Shortman. 2001. Human thymus contains 2 distinct dendritic cell populations. Blood 97:1733.
47. + blood monocytes. Eur. J. Immunol. 31:48.
48. + T cells. Int. Immunol. 13:1571.
49. Deveraux, Q. L., R. Takahashi, G. S. Salvesen, and J. C. Reed. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300.
50. Kataoka, T., M. Schroter, M. Hahne. P. Schneider, M. Irmler M. Thome, C. J. Froelich, and J. Tschopp. 1998. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and γ irradiation. J. Immunol. 161:3936.
51. Adams, J. M., and S. Cory. 2001. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:61.
52. Shi, Y. 2001. A structural view of mitochondria-mediated apoptosis. Nat. Struct. Biol. 8:394.
53. Bird, P. I. 1999. Regulation of pro-apoptotic leucocyte granule serine proteinases by intracellular serpins, Immunol. Cell. Biol. 77:47.
54. Medema, J. P., D. H. Schuurhuis, D. Rea. J. van Tongeren, J. de long, S. A. Bres, S. Laban, R. E. Toes, M. Toebes, T. N. Schumacher. et al. 2001. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194:657.
55. Scott, F. L., P. B. Coughlin, C. Bird, L. Cerruti, J. A. Hayman, and P. Bird. 1996. Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin. J. Biol. Chem. 271:1605.
56. Takai, Y., T. Masuko, and H. Takeuchi. 1997. Lipid structure of cytotoxic granules in living human killer T lymphocytes studied by Raman microspectroscopy Biochim. Biophys. Acta 1335:199.
57. Pham, C. T., and T. J. Ley. 1999. Dipeptidyl peptidase 1 is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. USA 96:8627.
58. Peters, P. J., J. Borst, V. Oorschot, M. Fukuda, O. Krahenbuhl, J. Tschopp, J. W. Slot, and H. J. Geuze. 1991. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173:1099.
59. Burkhardt, J. K., S. Hester, C. K. Lapham, and Y. Argon. 1990. The lyric granules of natural killer cells are dual-function organelles combining secretory and prelysosomal compartments. J. Cell Biol. 111:2327.
60. Page, L. J., A. J. Darmon, R. Uellner, and G. M. Griffiths. 1998. L is for lyric granules: lysosomes, that kill. Biochim. Biophys. Acta 1401:146.
61. Brunk. U. T., H. Dalen, K. Roberg, and H. B. Hellquist. 1997. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radical Biol. Med. 23:616.
62. Brunk, U. T., J. Neuzil, and J. W. Eaton. 2001. Lysosomal involvement in apoptosis. Redox. Rep. 6:91
63. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10:735.
64. Willingham, M. C., I. H. Pastan, and G. G. Sahagian. 1983. Ultrastructural immunocytochemical localization of the phosphomannosyl receptor in Chinese hamster ovary (CHO) cells. J. Histochem. Cytochem. 31:1.
65. Geuze, H. J., J. W. Slot, G. J. Strous, A. Hasilik, and K. Von Figura. 1984. Ultrastructural localization of the mannose 6-phosphate receptor in rat liver. J. Cell Biol. 98:2047.
66. Geuze, H. J., J. W. Slot, G. J. Strous, A. Hasilik, and K. von Figura. 1985. Possible pathways for lysosomal enzyme delivery. J. Cell Biol. 101:2253.
67. Braulke, T., C. Gartung, A. Hasilik, and K. von Figura. 1987. Is movement of mannose 6-phosphate-specific receptor triggered by binding of lysosomal enzymes? J. Cell Biol. 104:1735.
68. Griffiths, G., R. Matteoni, R. Back, and B. Hoflack. 1990. Characterization of the cation-independent mannose 6-phosphate receptor-enriched prelysosomal compartment in NRK cells. J. Cell Sci. 95:441.
69. Hindmarsh, E. J., M. A. Staykova, D. O. Willenborg, and C. R. Parish. 2001. Cell surface expression of the 300 kDa mannose-6-phosphate receptor by activated T lymphocytes. Immunol. Cell. Biol. 79:436.
70. Grouard, G., O. de Bouteiller, J. Banchereau, and Y. J. Liu. 1995. Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells. J. Immunol, 155:3345.
71. - T cells. J. Clin. Invest. 94:797.
72. + helper T cells. J. Exp. Med. 171:1315.
73. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-celI responses is mediated by CD40 signalling. Nature 393:478.
74. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
75. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161:5338.
76. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol 164:3095.
77. + T cells in vivo: implications for adaptive immunotherapy. Eur. J. Immunol. 31:1772.
78. Loyer, V., P. Fontaine, S. Pion, F. Hetu, D. C. Roy, and C. Perreault. 1999. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes. J. Immunol. 163:6462.
79. Kaiserman, D., S. Knaggs, K. L. Scarff, A. Gillard, G. Mirza, M. Cadman, R. McKeone, P. Denny, J. Cooley, C. Benarafa, et al. 2002. Comparison of human chromosome 6p25 with murine chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse. Genomics 79:349.
80. Res, P. C., F. Couwenberg, F. A. Vyth-Dreese, and H. Spits. 1999. Expression of pTα mRNA in a committed dendritic cell precursor tn the human thymus. Blood 94:2647.
81. Grouard, G., I. Durand, L. Filgueira, J. Banchereau, and Y. J. Liu. 1996. Dendritic cells capable of stimulating T cells in germinal centres. Nature 384:364.
82. - dendritic cells. Clin. Immunol. 100:325.
83. Held, W., R. MacDonald, and C. Mueller. 1990. Expression of genes encoding cytotoxic cell-associated serine proteases in thymocytes. Int. Immunol. 2:57.
84. Ebnet, K., C. N. Levelt, T. T. Tran, K. Eichmann, and M. M. Simon. 1995. Transcription of granzyme A and B genes is differentially regulated during lymphoid ontogeny. J. Exp. Med. 181:755.
85. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919.
86. Siegal, F. P. N. Kadowaki, M. Shodell. P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835.
87. Kadowaki, N., S. Antonenko, J. Y. Lau, and Y. J. Liu. 2000. Natural interferon α/β-producing cells link innate and adaptive immunity. J. Exp. Med. 192:219.
88. Cella, M., F. Facchetti, A. Lanzavecchia, and M. Colonna. 2000. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Nat. Immunol. 1:305.
89. Kannan-Thulasiraman P., and D. J. Shapiro. 2002. Modulators of inflammation use NF-κB and AP-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J. Biol. Chem. 277:41230.
90. + cytotoxic T lymphocytes. Hum. Immunol, 45:64.
91. + cytotoxic cytotoxic T lymphocytes in humans. Blood 95:2352.
92. Medema, J. P., J. de Jong, L. T. Peltenburg, E. M. Verdegaal, A. Gorter, S. A. Bres, K. L. Franken, M. Hahne, J. P. Albar, C. J. Melief, et al. 2001. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl. Acad. Sci. USA 98:11515.
93. Bladergroen, B. A., C. J. Meijer, R. L. ten Berge, C. E. Hack, J. J. Muris, D. F. Dukers, A. Chott, Y. Kazama. J. J. Oudejans. O. van Berkum, et al. 2002. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hogdkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99:232.
94. Ardavin, C., G. Martinez del Hoyo, P. Martin, F. Anjuere, C. F. Arias, A. R. Marin, S. Ruiz, V. Parrillas, and H. Hernandez. 2001. Origin and differqentiation of dendritic cells. Trends Immunol. 22:691.
95. Summers, K. L., B. D. Hoch, J. L. McKenzie, and D. N. J. Hart. 2001. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 159:285.